a Objective: Gender differences in immune response and the rate of disease progression in HIV-infected individuals have been reported but the underlying mechanism remains unclear, in part because of the lack of relevant animal models. Here, we report a novel nonhuman primate model for investigation of sex disparity in HIV disease progression.
Introduction
The sex of a host can significantly affect susceptibility to infections [1, 2] . Sex disparities have been reported for the prevalence of autoimmune [3] and infectious diseases [4] [5] [6] . Gender bias has also been observed in HIV-1 infection. Women with the same HIV-1 viral burden as men have a 1.6-fold higher risk of developing AIDS [7, 8] . Higher immune activation occurs in chronically infected women than men [9, 10] . This finding may explain the increased risk for disease progression in women, but the mechanism is not well understood.
The gut-associated lymphoid tissue is a major site of acute CD4
þ T-cell depletion and early viral replication in HIV/simian immunodeficiency virus (SIV) infection [11] . Disruption of the gut immune homeostasis is a hallmark of HIV/SIV infection and is central to disease pathogenesis [12] . The gastrointestinal tract also harbors the bulk of the human body's microorganisms [13] , with growing recognition that specific composition of the gut microbiota has a profound effect on host health and metabolic functions [14] . The gut microbiome also plays a pivotal role in maintaining mucosal and systemic immune cell homeostasis, and is important for the induction of host innate responses and systemic immunity [15, 16] . Notably, recent evidence indicates the innate immune response during acute infection impacts HIV/SIV disease progression [17] . However, without an animal model, it is difficult to dissect the association between innate immune activation and microbial changes during acute infection of HIV/SIV with gender differences in disease progression.
We now report the development and characterization of a nonhuman primate (NHP) model that replicates the gender differences in AIDS progression in humans. The sex bias disease susceptibility seen in rhesus macaques infected intrarectally with R5 simian HIVs (SHIVs) does not appear to be due to a difference in the basal innate immune environment in the rectal lumen. Rather, an exploratory longitudinal study in six infected animals revealed sex differences in gut innate immune and microbiota response to infection. These findings add to the growing awareness that sex is an important source of biological, immunological, and microbial variation. They further highlight the importance of including female animals in preclinical research per recent National Institutes of Health policy [18] .
Materials and methods

Animal welfare statement
The study was carried out in strict accordance with the Guide for the Care and use of Laboratory Animals of the National Institutes of Health. The protocol was approved by the Institutional Animal Care and Use Committee of the Tulane National Primate Research Center.
Simian HIV infection of rhesus macaques All intrarectal inoculations were carried out in 4-14 years old rhesus monkeys (Macaca mulatta) of Indian descent bred and housed at the Tulane National Primate Research Center. Animals were confirmed to be serologically and virus negative for simian type D retrovirus, and serologically negative for SIVand simian T-cell lymphotropic virus prior to infection. They were also screened for the presence of the Mamu-A Ã 01, Mamu-B Ã 08, and Mamu-B Ã 17 class I allele previously shown to be associated with spontaneous control of pathogenic SIVmac239 replication by standard PCR with allele-specific primers [19] . Macaques received a single 5 Â 10 3 50% tissue culture infectious dose of the lineagerelated subtype C R5 SHIVC109P3 or SHIVC109P3N viruses [20] . Plasma viremia was quantified by real-time RNA PCR (Washington National Primate Research Center) and absolute CD4
þ and CD8 þ cell counts were monitored in TruCount tubes (BD Biosciences, Palo Alto, California, USA). Animals exhibiting clinical signs of AIDS (peripheral blood CD4
þ T-cell depletion [< 200 cells/ml], greater than 25% loss of body weight, or combinations of the following conditions: diarrhea unresponsive to treatment, opportunistic infections, peripheral lymph node atrophy, and abnormal hematology) were euthanized by intramuscular administration of telazol and buprenorphine followed by an overdose of sodium pentobarbital.
Specimen collection and preparation
Rectal samples were obtained by gently inserting Merocel Eye Spear (Beaver-Visitec, Waltham, Massachusetts, USA) into the rectum for 5 min to absorb mucosal fluid. The specimens were immediately placed on ice and stored in a À808C freezer. For analysis, 0.8 ml cold, sterile phosphate-buffered saline was added to the swabs, and the recovered eluates were centrifuged. Supernatants were collected and cryopreserved for chemokine/cytokine analysis. For the study in six animals to monitor longitudinal immune and microbial responses, rectal samples were not obtained on the day of infected intrarectally challenge with SHIVC109P3 to minimize irritation at the inoculation site. Supernatants of the rectal eluates collected 2 weeks before and at various time points postchallenge were used for immunological studies and the pellets were subjected to DNA extraction for microbiome analysis. Fresh stool under the cage pan was also collected over time for the six animals and stored frozen. For analysis, 1 ml cold phosphate-buffered saline was added to approximate 2 g of frozen stool, vortexed briefly, and cleared by centrifugation.
Multiplex cytokine/chemokine assay Cytokines and chemokines in rectal secretions and plasma samples were analyzed using a MAGPIX multiplexing instrument (EMD Millipore, Billerica, Massachusetts, USA) and MILLIPLEX map Non-Human primate cytokine multiplex kits (cat# PCYTMG-40K-PX23) from Millipore according to the manufacturer's instructions. Results were analyzed using Millipore Analyst software.
DNA extraction and PCR amplification
Total DNA was extracted from the particulate fraction of the swab and fecal specimens collected using the MoBio Power Soil II Kit (MoBio, Carlsbad, California, USA). DNA concentrations and purity were determined using a NanoDrop 2000 UV-Vis Spectrophotometer (NanoDrop products, Wilmington, Delaware, USA). 16S rRNA genes were amplified using a primer set spanning the V3 and V4 regions, as previously described [21] . The forward primer 347F was modified by a 5 0 -addition of a 6-mer nucleotide barcode to serve as a multiplex identifier and a two-base linker sequence (AG); the reverse primer 803R was tagged with a different multiplex identifier. PCR amplicons were purified using Agencourt AMPure XP (Beckman Coulter, Inc., Indianapolis, Indiana, USA), and multiplexed by pooling at equal molarity and then ligated to Illumina adaptors of PE Read 1 and Read 2 sequencing primers (PE Read 1 sequencing primer 5 0 ACACTCTTTCCCTA CACGACGCTCTTCCGATCTand PE Read 2 sequencing primer 5 0 CGGTCTCGGCATTCCTGCTGA ACCG-CTCTTCCGATCT) for MiSeq sequencing (Illumina, San Diego, California, USA).
Amplicon-based data analysis Sequence reads were trimmed based on quality score 30 and maximum number of ambiguities two. The high-quality reads were then merged paired ended into longer sequences, and the merged sequences with lengths between 350 and 600 bp were selected for downstream analysis. Selected reads were demultiplexed into samples according to the barcodes using software Quantitative Insights Into Microbial Ecology (QIIME) with default parameters. In all, 5 139 359 high-quality sequences were analyzed. Each sample yielded an average of 22 741 (AE9531) sequences, ranging from 8747 to 47 174. Operational taxonomic units clustering was done at a 97% similarity threshold. Taxonomic identities were assigned using the Ribosomal Database Project classifier included in the QIIME with a confidence threshold of 0.8. Relative abundances of the taxa at the phylum, class, and genus levels were calculated.
Statistics
Survival for the infected male and female rhesus macaques was compared using a log-rank test (GraphPad Prism 5; GraphPad Software, Inc., La Jolla, California, USA). Differences in survival were considered significant when P < 0.05. Comparison of cytokine/chemokine levels in the rectalsecretionsofuninfectedfemaleandmalemacaqueswas performed using Mann-Whitney U test, and statistical analysis of the response in the two groups to viral infection was performed with SAS 9.3 (SAS Institute, Inc., Cary, North Carolina, USA). Briefly, each cytokine response at each time point was normalized by dividing its value by its corresponding preinfection value. A log-binomial regression model of this binary variable using a repeated measures approach with each repeat defined by a cytokinetime point combination was generated, and generalized equations and SAS proc genmod were used to estimate the repeated measures model, assuming an exchangeable correlation structure [22] . Independent variables considered were sex and time since infection, as well as an interaction term. Model coefficientswere exponentiated toestimate the relative risk (RR) of an elevated (>AE2.0) cytokine value for female vs. male macaques at each time point; 95% confidence intervals (CIs) for which the lower bound exceeded 1 correspond to statistical significance at the 0.05 level. Significance of differences in peak viremia (log transformed) and differences in a specific taxon between two groups of samples were calculated based on relative abundance using Mann-Whitney U test.
Results
R5 simian HIV intrarectally infected female rhesus macaques progressed faster to disease than male macaques
We recently reported the generation of lineage-related, mucosally transmissible subtype C R5 SHIVC109 viruses that are capable of AIDS development, induction of neurological disease, and coreceptor switching in rhesus Sex disparity in simian HIV disease susceptibility Ren et al. macaques [20] . We found no significant differences in the abilityof the viruses to initiate and establish an infection with intrarectal inoculation in male and female rhesus macaques (Fig. 1 ). All 11 female macaques and 9 of 10 male macaques developed systemic infection following a single high-dose challenge (Fig. 1a) . The sexes were comparable in age. None of the male macaques expressed the restrictive Mamu-A Ã 01, Mamu-B Ã 08 and Mamu-B Ã 17 class I alleles, but one female was macaque Mamu-A Ã 01 positive and another was Mamu-B Ã 17 positive. Plasma viremia peaked at 2-3 weeks postinfection (wpi) in all infected monkeys, and no significant differences in magnitude were observed between the sexes (Fig. 1b) . However, a rapid progressor phenotype characterized by sustained high viral loads and weak or absence of antiviral antibody response was seen only in females. Accordingly, the tempo of clinical AIDS development was faster in the infected females than males (P ¼ 0.0105; Fig. 1c ).
Comparable basal innate immune milieu in the rectal mucosa of male and female rhesus macaques Women have been reported to have higher levels of immune activation and inflammation in the gut environment than men, which may predispose women to inflammation-associated diseases [23] . We first investigated the possibility of sex-based differences in the gut mucosal environment of rhesus macaques prior to infection by comparing the levels of chemokines, cytokines, and growth factors in rectal swab eluates of naive female (n ¼ 11) and male (n ¼ 9) monkeys. There were no significant differences between the sexes in the levels of soluble immune mediators measured (Fig. 2) . These findings suggest that the faster disease progression in female rhesus macaques was not because of a more inflamed mucosal immune milieu before infection.
Acute mucosal inflammatory innate immune and microbiome response is more robust in R5 simian HIV-infected females than males Mounting evidence points to a role of acute regional innate immunity in the control or development of disease [17] . Accordingly, we conducted a pilot study using six animals challenged intrarectally with SHIVC109P3 to measure chemokine/cytokine levels over time in the rectal swab eluates. Moreover, given the known interplay between innate immunity and resident bacterial communities in the gut [14] [15] [16] , we also investigated shifts in the gut microbiota of infected animals. None of the six animals expressed the class I alleles reported to be associated with spontaneous virologic control of pathogenic SIV replication. Initial viremia similar to acute HIV infection (10 6 -10 7 RNA copies/ml plasma) was seen in both infected females (n ¼ 3) and male (n ¼ 3) macaques (Supplemental Figure  1A , http://links.lww.com/QAD/A697). Virus replication declined postpeak, establishing various set points. CD4 Basal rectal mucosal innate immune mediator levels in male and female rhesus macaques. Immune mediators in rectal swab elutes from naive male (n ¼ 9) and female (n ¼ 11) macaques were analyzed by multiplex assays. Data represent median and interquartile range. Significance values were calculated with nonparametric two-tailed Mann-Whitney U test. P < 0.05 was considered significant.
T-cell loss accompanied acute infection in the viremic animals, with levels rebounded close to preinfection values in most of the infected animals by 10 wpi (Supplemental Figure 1B , http://links.lww.com/QAD/A697). The exception was DF73, the rapid progressor female macaque with high chronic viremia. Precipitous drop in peripheral CD4 þ T-cell numbers was seen in this animal at 10 wpi, with clinical AIDS development and euthanasia 5 weeks later. In contrast, and despite comparable viral load and absence of detectable antiviral antibody response in ER57, this male macaque remained clinically healthy during the 30-week observation period.
Longitudinal immune assessments indicated a more rapid and robust local innate immune response in the infected female than male macaques (Fig. 3) . Sex differences in upregulation of innate immunity were noticeable at day 3 postinfection, and were sustained during the acute (d3-28) and postacute (d35-175) stages of infection. As a group, the proinflammatory cytokine response (e.g., sCD40L, interleukin-12, interferon [IFN] g, and tumor necrosis factor [TNF] a) and inflammasome response (interleukin-1b) were more robust in females than males. Moreover, the marked induction of IFN-g and interleukin-12 in two of the three infected females at day 3 after inoculation suggests early activation of T cells and dendritic cells at the site of virus infection. The peripheral innate immune response overall was less robust in all infected macaques, with no notable differences between the sexes, thus, highlighting the importance of local tissue sampling and analysis (Supplemental Figure 2 , http://links.lww.com/QAD/A697). The use of a more sensitive detection method, such as gene expression analysis may reveal higher levels of acute immune activation in the periphery and sex-based differences. Although the cohort was small, the number of longitudinal specimens collected per animal was large, providing sufficient statistical power for comparisons of mucosal innate responses between the sexes. During the acute phase Fig. 3 . Gender differences in rectal immune response to R5 simian HIV-infected intrarectally challenge. Fold change in analyte levels over time in rectal swab eluates of SHIVC109P3-IR-infected male (n ¼ 3) and female (n ¼ 3) macaques. Color scale for downregulation (in blue) and upregulation (in red) is shown on the right. SHIV, simian HIV. (d3-28), the three female animals were 2.6 times as likely (RR; 95% CI ¼ 2.1, 3.2) as the three male macaques to have elevated (>2) cytokine levels. At all subsequent postinfection time points (d35-175), the female macaques were more than three times as likely to have elevated cytokine levels (RR ¼ 3.4; 95% CI ¼ 2.7, 4.2).
Analysis of bacterial community structures adherent to the mucosal surface in rectal swabs and of transitory bacteria in the form of feces in the lumen showed microbial community composition changes in all infected animals. Changes were more prominent in the rectal mucosa than in the lumen (Fig. 4) , which could help explain why early studies failed to show an association between pathogenic SIV infection and changes in the luminal bacteria at the family level [24, 25] . The main change in the rectal mucosa was enrichment along the Proteobacteria-Epsilonproteobacteria lineage, and the scale of this enrichment was significantly higher in female than male macaques, especially during acute infection (MannWhitney U test, 31.15 vs. 12.77%, P < 0.01 for Proteobacteria and 28.1 vs. 11.1%, P < 0.01 for Epsilonproteobacteria, respectively). We employed linear discriminant analysis effect size (LEfSe) method [26] to identify bacterial taxa that might be informative of differences in mucosal bacterial community responses between male and female macaques during the acute phase. Six genera were differentially represented (Fig. 5a ). Flexispira (P < 0.01), Bacteroides (P < 0.001), and Helicobacter (P < 0.01) were significantly enriched in female mucosal samples (Fig. 5b) , whereas Prevotella (P < 0.001), Streptococcus (P < 0.01), and Blautia (P < 0.001) were overly represented in male mucosal samples (Fig. 5c ).
Discussion
In this study, we presented evidence for a novel NHP model of sex inequality in disease risk that recapitulates the sex bias in HIV-1 disease progression in humans (Fig. 1) . Gender-based differences in basal immune activation and inflammation in the gut lumen of macaques do not appear to be contributing factors (Fig. 2) , but a previously unrecognized sex disparity in local innate immunity and microbial response to SHIV infection was observed. Although there is some degree of heterogeneity between these outbred animals within each sex, an earlier, stronger and proinflammatory skewed chemokine/cytokine response was seen in the rectal mucosa of two of the three SHIV-infected female macaques (Fig. 3) , consistent with previous studies in humans that females generally mount a more potent innate immune response, as well as a stronger Th1-biased adaptive immune response, than do males following infection or vaccination [27] . Moreover, there were notable changes in the gut microbiota during the acute phase of SHIV infection of both sexes, but the magnitude of the microbial community shift as well as enrichment of adherent Proteobacteria in the rectal mucosa of female macaques was significantly higher than male macaques (Fig. 4) . At the taxa level, Flexispira, Bacteroides, and Helicobacter predominated in female mucosal samples but not in male samples (Fig. 5) . Mechanistically, increased expression of interleukin-1b and other inflammatory cytokines (e.g. IFN-g, TNF-a) has been shown to disrupt epithelial barrier integrity [28, 29] , and is associated with microbial translocation and chronic immune activation, markers of HIV/SIV disease progression [30] [31] [32] . In humans, HIV infection is associated with an increase of Proteobacteria accompanied by decreases of Firmicutes and Bacterioidia [33] [34] [35] [36] , similar to the profile observed in inflammatory gastrointestinal conditions [34, [37] [38] [39] . Notably, the increase in Proteobacteria in HIV patients is associated with markers of mucosal immune disruption, T-cell activation, and chronic inflammation. A positive association between Bacteroidales and CD8 þ T-cell activation had also been reported [40] , and in mouse models, Helicobacter hepaticusinduced inflammatory bowel disease is more severe in females than in males [41] . Our finding that innate immune mediators and bacterial species associated with gut immune activation and damage are augmented early in the rectal mucosa of infected female than male macaques, therefore, is of interest, and is consistent with a more inflammatory tone in the rectal mucosa of infected females than males, which could contribute to faster disease progression in females.
In summary, nearly more than half of the 30 million adults newly infected with HIV worldwide are women, and unprotected anal receptive intercourse is practiced by members of this sex [42, 43] . A better understanding of the host innate immune and microbial interactions that might contribute to the sex disparity in disease seen in this novel NHP model of HIV infection therefore could inform the development of comprehensive and effective healthcare of infected women.
